CACLP & CISCE 2024 Draw Global Attention to Innovations and Collaborations in IVD Industry

Chongqing, China - From 16 to 18 March 2024, the bustling halls of Chongqing International Expo Center witnessed a remarkable convergence of innovations and advancements, as the 21st China Association of Clinical Laboratory Practice Expo (CACLP) and the 4th edition of China IVD Supply Chain Expo (CISCE) concluded with resounding success.

Occupying an expansive 130,000 sqm exhibiting area across 9 halls, CACLP & CISCE 2024 hosted over 1,346 global exhibitors spanning the in vitro diagnostics (IVD) industry chain. In a continuous effort to enhance the experience for both exhibitors and visitors, for the first time ever, the two expos were thoughtfully divided into 6 specialized areas (Instruments and Reagents, Raw Materials, Components, Consumables, General Lab Equipment, and Supply Chain) and ensured a more focused and impactful engagement for all involved.

The impact of CACLP & CISCE 2024 was evident as 42,751 visitors, comprising industry professionals, researchers, and end users, flooded the event by its closure on 18 March. With exhibitors hailing from 19 countries and regions, and professional visitors representing 40 nations, Chongqing became a global hub of IVD innovation during the event. 

Notable participants, including international giants such as Danaher Corporation, Roche and Abbott, as well as prominent Chinese IVD companies like Zybio, Mindray, YHLO, Maccura, Autobio, Wondfo and Snibe, together with the Berlin-Brandenburg joint-booth exhibitors and the Association of Diagnostics Manufacturers of India, significantly enriched the exhibition's diverse array of offerings. Additionally, the introduction of daily roadshows at the International Pavilion provided an integrated and targeted stage for exhibitors to spotlight cutting-edge products and technologies on a global scale.

From 15-17 March, the 9th China Experimental Medicine Conference (CEMC) and series sessions, the 11th China IVD Industry Development Conference (CIIDC), the 6th China IVD Distribution Enterprise Forum (CIDEF), Enlightening Lab Med - the 7th IVD Youth Entrepreneur Forum (ELM·Y), the 4th China Key Raw Material & Parts Forum (CKRMPF) as well as the 1st International Laboratory Medicine & IVD Forum, were successfully held.

The concurrent academic events welcomed 315 academicians, renowned experts and scientists in experimental medicine, biomedical engineering and related fields, delivering captivating presentations and attracted over 5000 attendees onsite. Besides, the 11th CIIDC marked the official release of the latest In Vitro Diagnostic Industry in China, and The Annual Report of China IVD Industry, providing comprehensive analysis and authoritative insights into the field. At the 9th CEMC, Prof. Khosrow Adeli, past president of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC), officially signed the strategic cooperation agreement between IFCC and PCEM & CAIVD & CACLP. The 1st International Laboratory Medicine & IVD Forum, jointly organized by CAIVD, PCEM and IFCC and hosted by CACLP, greatly facilitated global academic exchange.

The influx of international participants at CACLP & CISCE 2024 brought forth diverse opportunities and collaborations, revitalizing both China's and the Asia-Pacific IVD market. Our commitment to Shaping A Smarter Future Through Collaboration was underscored throughout the 2024 event, serving as a catalyst for continuous innovation, collaboration, and advancement in the IVD field. Looking ahead, an increased international engagement can be anticipated in our upcoming academic events and we remain dedicated to realizing new goals that drive the industry forward.

The 22nd CACLP and 5th CISCE will return next March, stay tuned with us.

For further information, please visit https://en.caclp.com/

About GL events

GL events is a world-class leading provider of integrated solutions and services for events operating across the 3 major core divisions: Venues (venue management), Exhibitions (exhibition organizing) and Live (event services).

Through its wide global network made up of more than 90 offices, with organizing over 480 proprietary trade fair and events, managing more than 60 venues, and staging more than 4,200 events every year, GL events Group is a critical force for city promotion of 28 MICE destinations.

Present on five continents with operations in more than 20 countries, GL events has over 5,119 employees. Listed on the Eurolist Euronext Compartment B (Paris Stock Exchange), GL events had a turnover of €1.315bn in 2022.

About CACLP

Debut launched in 1991, CACLP, the China Association of Clinical Laboratory Practice Expo, is well established as one of the largest exhibitions in the in vitro diagnostic industry worldwide. CISCE, China IVD Supply Chain Expo, successfully launched in 2021, further expands the product sectors from upstream to downstream. With a great number of high-level academic and educational programs held concurrently onsite, and year-round promotional solutions, CACLP proves itself as one of the most important platforms for global IVD players.

In 2020, CACLP formed the joint-venture company with GL events to start the internationalism strategy.